A sychnological cell penetrating peptide mimic of p21(WAF1/CIP1) is pro-apoptogenic

Rachael D Baker1, John Howl, Iain D Nicholl

  • 1Research Institute in Healthcare Science, School of Applied Sciences, University of Wolverhampton, Wolverhampton WV1 1SB, United Kingdom.

Peptides
|February 9, 2007
PubMed

Insights

This study developed a novel nuclear delivery system using a HIV-1 protein transduction domain (Tat) to deliver a cytotoxic peptide. The Tat-peptide construct effectively induced cancer cell apoptosis by disrupting nuclear PCNA function.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Targeting chemotherapeutic agents to DNA replication and repair sites in cancer cells is challenging.
  • Nuclear delivery of cytotoxic peptides requires effective transport mechanisms.

Purpose of the Study:

  • To develop a method for nuclear delivery of biologically active peptides.
  • To investigate the potential of a Tat-peptide construct for disrupting cancer cell growth.

Main Methods:

  • Utilized the HIV-1 transactivator of transcription protein transduction domain (Tat(48-60)) for nuclear peptide delivery.
  • Constructed Tat(48-60)-P10, a fusion peptide containing the p21(WAF1/CIP1) mimic and a PIP box.
  • Assessed cytotoxicity and nuclear PCNA colocalization via immunofluorescence in glioma cell lines.

Main Results:

  • Demonstrated successful nuclear delivery of peptides using Tat(48-60).
  • Tat(48-60)-P10 induced apoptosis, dependent on the wild-type PIP box sequence.
  • Observed colocalization of Tat(48-60)-P10 with nuclear PCNA, suggesting disruption of its function.
  • U251 and U373 glioma cells showed significant sensitivity to the construct.

Conclusions:

  • The Tat(48-60) domain is effective for nuclear delivery of cytotoxic peptides.
  • Tat(48-60)-P10 exhibits cancer-specific cytotoxicity potentially through PCNA interaction disruption.
  • This approach offers a promising strategy for targeted cancer therapy.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.